Novo Nordisk A/S
NONOF
$49.68
$0.160.32%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 33.74% | -22.26% | -1.57% | 1.52% | 0.28% |
| Total Depreciation and Amortization | -5.17% | -20.59% | 18.26% | 82.00% | -0.33% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -253.93% | 437.68% | -29.55% | 125.27% | -219.81% |
| Change in Net Operating Assets | 508.64% | -207.42% | 131.21% | -219.20% | 217.13% |
| Cash from Operations | -83.56% | 16.42% | 78.85% | 97.32% | -72.79% |
| Capital Expenditure | -34.56% | 4.28% | -17.79% | 17.72% | -28.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -196.95% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,305.70% | -548.07% | -93.40% | 4.40% | 170.44% |
| Cash from Investing | -176.17% | -11.49% | -130.24% | 92.78% | -323.20% |
| Total Debt Issued | 4,194.53% | -98.42% | 65.31% | -38.87% | 37,512.61% |
| Total Debt Repaid | -0.61% | 98.23% | -439.04% | -2,678.75% | 18.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 100.00% | 81.47% | -211.48% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 100.00% | -- | -- | -- | 100.00% |
| Other Financing Activities | -- | -- | -200.00% | -- | -- |
| Cash from Financing | 271.50% | 61.92% | -1,014.54% | -85.39% | 294.14% |
| Foreign Exchange rate Adjustments | 67.42% | 108.01% | -915.65% | -111.84% | 299.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.97% | 168.55% | -194.96% | 155.56% | -1,055.82% |